Whole Genome Sequencing (WGS) for Cronobacter and other Pathogens in Infant Formula Webinar
On March 8th, 2023, the FDA released a letter calling for enhanced safety measures for powdered infant formula. In this letter there was guidance to infant formula manufacturers in relation to Cronobacter incidents in 2022 as follows:
"FDA strongly recommends using WGS (and the public database of genomes available at the National Center for Biotechnology Information) to analyze and investigate any pathogen isolated from a production environment or product". https://www.fda.gov/media/166044/download
In this webinar we:
- Review this call to action from the FDA.
- Provide an overview of the technology of whole genome sequencing.
- Discuss the benefits of whole genome sequencing.
- Review the ways that Eurofins is ready to support your testing needs.
- Hold a live Q&A session
Original airdate: Thursday, May 18, 2023
Length: 45 minutes
Presenters:
Keren Breiterman - Business Development Director; Eurofins Food Chemistry Testing, Madison
Andrzej Benkowski - Technical Leader; Eurofins Microbiology Laboratories, Inc.
